Pharmacologyq2Illustratedq 2 Reviewsq27thq2Editionq2Whalenq2Testq2B
ankq2TABLEq2OFq2CONTENT
Chapterq 2 1:q 2 Pharmacokinetics
Chapterq22:q2Drug–
Receptorq2Interactionsq2andq2Pharmacodynamicsq 2 Chapterq23:q 2
Theq 2 Autonomicq2Nervousq2System
Chapterq24:q2Cholinergicq2Agonistsq
2Chapterq25:q2Cholinergicq2Antagon
istsq2Chapterq26:q2Adrenergicq2Ago
nistsq2Chapterq27:q2Adrenergicq2Ant
agonists
Chapterq28:q2Drugsq2forq2Neurodegenerativeq2Disease
sq2Chapterq29:q2Anxiolyticq2andq2Hypnoticq2Drugs
Chapterq210:q2Antidepressantsq2Cha
pterq211:q2Antipsychoticq2Drugsq2C
hapterq212:q2Drugsq2forq2Epilepsyq2
Chapterq213:q2Anesthetics
Chapterq 2 14:q 2 Opioids
Chapterq215:q2Drugsq2ofq2Abuseq2C
hapterq216:q2CNSq2Stimulantsq2Cha
pterq217:q2Antihypertensivesq2Chap
terq218:q2Diuretics
Chapterq 2 19:q 2 Heartq 2 Failure
Chapterq220:q2Antiarrhythmicsq2Cha
pterq221:q2Antianginalq2Drugs
Chapterq222:q2Anticoagulantsq2andq2Antiplateletq2Age
ntsq 2 Chapterq223:q2Drugsq2forq2Hyperlipidemia
Chapterq224:q2Pituitaryq2andq2Thyro
idq2Chapterq225:q2Drugsq2forq2Diabe
tes
Chapterq226:q2Estrogensq2andq2Androgensq2C
hapterq227:q2Adrenalq2Hormones
Chapterq2 28:q 2 Drugsq 2 forq 2 Obesity
Chapterq229:q2Drugsq2forq2Disordersq2ofq2theq2Respiratoryq2System
q 2 Chapterq230:q2Antihistamines
Chapterq231:q2Gastrointestinalq2andq2Antiemeticq2Dru
gsq2Chapterq232:q2Drugsq2forq2Urologicq 2 Disorders
Chapterq 2 33:q 2 Drugsq 2 forq 2 Anemia
Chapterq234:q2Drugsq2forq2Dermatologicq2Disordersq2
Chapterq235:q2Drugsq2forq2Boneq2Disorders
Chapterq236:q2Anti-
inflammatory,q2Antipyretic,q2andq 2 Analgesicq2Agentsq 2 Chapterq237:q 2 Pri
nciplesq2ofq 2 Antimicrobialq 2 Therapy
Chapterq2 38:q 2 Cellq2 Wallq 2 Inhibitors
Chapterq 2 39:q 2 Proteinq 2 Synthesisq 2 Inhibitors
Chapterq240:q2Quinolones,q2Folicq2Acidq 2 Antagonists,q 2 andq 2 Urinaryq 2 Tractq2Antisep
ticsq2Chapterq241:q2Antimycobacterialq2Drugs
Chapterq242:q2Antifungalq2Drugsq2C
hapterq243:q2Antiprotozoalq2Drugsq2
Chapterq244:q2Anthelminticq2Drugsq
2Chapterq245:q2Antiviralq2Drugs
Chapterq 2 46:q 2 Anticancerq 2 Drugs
Chapterq247:q2Immunosuppressantsq
2Chapterq248:q2Clinicalq2Toxicology
Plusbay.Plus
,Plusbay.Plus
,3. Theq2nurseq2isq2teachingq2aq2patientq2whoq2willq2beq2dischargedq2homeq2withq2aq2prescriptionq2forq2an
q2 enteric-
q2 coatedq2tablet.q2Whichq2statementq2byq2theq2patientq 2 indicatesq2understandingq2ofq2theq2teaching?
a. Iq2mayq2crushq2theq2tabletq2andq2putq2itq2inq2applesauceq2toq2improveq2absorption.
b. Iq2shouldq2 consumeq2acidicq2foodsq2toq2enhanceq2absorptionq2ofq2thisq2medication.
c. Iq2 shouldq 2 expectq2 aq2delayq2inq2onsetq2 ofq2theq2drugsq2effectsq2afterq2takingq2theq2tablet.
d. Iq2shouldq2takeq2thisq2medicationq2withq2high-
fatq2foodsq2toq2improveq2itsq2action.q2ANS:q2C
Enteric-
coatedq2tabletsq2resistq2disintegrationq2inq2theq2acidicq2environmentq2ofq2theq2stomachq2andq2disintegr
ateq2whenq2theyq2reachq2theq2smallq2intestine.q2Thereq2isq2usuallyq2someq2delayq2inq2onsetq2ofq2actionsq2
afterq2takingq2theseq2medications.q2Enteric-
coatedq2tabletsq2shouldq2notq2beq2crushedq2orq2chewed,q2whichq2wouldq2alterq2theq2timeq2andq2location
q2 ofq2absorption.q2Acidicq2foodsq2willq2notq2enhanceq2theq2absorptionq2ofq2theq2medication.q2Theq2patie
ntq2shouldq2notq2toq2eatq2high-fatq2foodq2beforeq2ingestingq2anq2enteric-
coatedq2tablet,q2becauseq2high-fatq2foodsq2decreaseq2theq2absorptionq2rate.
DIF:q2COGNITIVEq2LEVEL:q2Applyingq2(Application)q2REF:q2dmq2
3q2TOP:q2NURSINGq2PROCESS:q2Nursingq2Intervention
MSC:q2NCLEX:q2Physiologicalq2Integrity:q2Pharmacologicalq2andq2 Parenteralq2Therapies
4. Aq2patientq2whoq2isq2newlyq2diagnosedq2withq2typeq21q2diabetesq2mellitusq2asksq2whyq2insulinq2m
ustq2beq2givenq2byq2subcutaneousq2injectionq2insteadq2ofq2byq2mouth.q2Theq2nurseq2willq2explainq2thatq
2thisq2isq2because
a. absorptionq2isq2 diminishedq2 byq2theq2first-passq2effectsq2inq2theq2liver.
b. absorptionq2isq2fasterq2whenq2insulinq2isq2givenq2subcutaneously.
c. digestiveq2enzymesq2inq2theq2gastrointestinalq2tractq2preventq2absorption.
d. theq2oralq2formq2isq2lessq2predictableq2withq2moreq2adverseq2eff
ects.q2ANS:q2C
Insulin,q2growthq2hormones,q2andq2otherq2protein-
basedq2drugsq2areq2destroyedq2inq2theq2smallq2intestineq2byq2digestiveq2enzymesq2andq2mustq2beq2given
q2 parenterally.q2Becauseq2insulinq2isq2destroyedq2byq2digestiveq2enzymes,q2itq2wouldq2notq2makeq2itq2t
oq2theq2liverq2forq2metabolismq2withq2aq2first-
passq2effect.q2Subcutaneousq2tissueq2hasq2fewerq2bloodq2vessels,q2soq2absorptionq2isq2slowerq2inq2suchq
2tissue.q2Insulinq2isq2givenq2subcutaneouslyq2becauseq2itq2isq2desirableq2toq2haveq2itq2absorbq2slowly.
Pageq 2 2q 2 ofq 2 507
Plusbay.Plus
, DIF:q2COGNITIVEq2LEVEL:q2Understandingq2(Comprehension)q2REF:q2dmq2
3q2TOP:q2NURSINGq2PROCESS:q2Nursingq2Intervention:q2Patientq2Teaching
MSC:q2NCLEX:q2Physiologicalq2Integrity:q2Pharmacologicalq2andq2 Parenteralq2Therapies
Pageq 2 3q 2 ofq 2 507
Plusbay.Plus
ankq2TABLEq2OFq2CONTENT
Chapterq 2 1:q 2 Pharmacokinetics
Chapterq22:q2Drug–
Receptorq2Interactionsq2andq2Pharmacodynamicsq 2 Chapterq23:q 2
Theq 2 Autonomicq2Nervousq2System
Chapterq24:q2Cholinergicq2Agonistsq
2Chapterq25:q2Cholinergicq2Antagon
istsq2Chapterq26:q2Adrenergicq2Ago
nistsq2Chapterq27:q2Adrenergicq2Ant
agonists
Chapterq28:q2Drugsq2forq2Neurodegenerativeq2Disease
sq2Chapterq29:q2Anxiolyticq2andq2Hypnoticq2Drugs
Chapterq210:q2Antidepressantsq2Cha
pterq211:q2Antipsychoticq2Drugsq2C
hapterq212:q2Drugsq2forq2Epilepsyq2
Chapterq213:q2Anesthetics
Chapterq 2 14:q 2 Opioids
Chapterq215:q2Drugsq2ofq2Abuseq2C
hapterq216:q2CNSq2Stimulantsq2Cha
pterq217:q2Antihypertensivesq2Chap
terq218:q2Diuretics
Chapterq 2 19:q 2 Heartq 2 Failure
Chapterq220:q2Antiarrhythmicsq2Cha
pterq221:q2Antianginalq2Drugs
Chapterq222:q2Anticoagulantsq2andq2Antiplateletq2Age
ntsq 2 Chapterq223:q2Drugsq2forq2Hyperlipidemia
Chapterq224:q2Pituitaryq2andq2Thyro
idq2Chapterq225:q2Drugsq2forq2Diabe
tes
Chapterq226:q2Estrogensq2andq2Androgensq2C
hapterq227:q2Adrenalq2Hormones
Chapterq2 28:q 2 Drugsq 2 forq 2 Obesity
Chapterq229:q2Drugsq2forq2Disordersq2ofq2theq2Respiratoryq2System
q 2 Chapterq230:q2Antihistamines
Chapterq231:q2Gastrointestinalq2andq2Antiemeticq2Dru
gsq2Chapterq232:q2Drugsq2forq2Urologicq 2 Disorders
Chapterq 2 33:q 2 Drugsq 2 forq 2 Anemia
Chapterq234:q2Drugsq2forq2Dermatologicq2Disordersq2
Chapterq235:q2Drugsq2forq2Boneq2Disorders
Chapterq236:q2Anti-
inflammatory,q2Antipyretic,q2andq 2 Analgesicq2Agentsq 2 Chapterq237:q 2 Pri
nciplesq2ofq 2 Antimicrobialq 2 Therapy
Chapterq2 38:q 2 Cellq2 Wallq 2 Inhibitors
Chapterq 2 39:q 2 Proteinq 2 Synthesisq 2 Inhibitors
Chapterq240:q2Quinolones,q2Folicq2Acidq 2 Antagonists,q 2 andq 2 Urinaryq 2 Tractq2Antisep
ticsq2Chapterq241:q2Antimycobacterialq2Drugs
Chapterq242:q2Antifungalq2Drugsq2C
hapterq243:q2Antiprotozoalq2Drugsq2
Chapterq244:q2Anthelminticq2Drugsq
2Chapterq245:q2Antiviralq2Drugs
Chapterq 2 46:q 2 Anticancerq 2 Drugs
Chapterq247:q2Immunosuppressantsq
2Chapterq248:q2Clinicalq2Toxicology
Plusbay.Plus
,Plusbay.Plus
,3. Theq2nurseq2isq2teachingq2aq2patientq2whoq2willq2beq2dischargedq2homeq2withq2aq2prescriptionq2forq2an
q2 enteric-
q2 coatedq2tablet.q2Whichq2statementq2byq2theq2patientq 2 indicatesq2understandingq2ofq2theq2teaching?
a. Iq2mayq2crushq2theq2tabletq2andq2putq2itq2inq2applesauceq2toq2improveq2absorption.
b. Iq2shouldq2 consumeq2acidicq2foodsq2toq2enhanceq2absorptionq2ofq2thisq2medication.
c. Iq2 shouldq 2 expectq2 aq2delayq2inq2onsetq2 ofq2theq2drugsq2effectsq2afterq2takingq2theq2tablet.
d. Iq2shouldq2takeq2thisq2medicationq2withq2high-
fatq2foodsq2toq2improveq2itsq2action.q2ANS:q2C
Enteric-
coatedq2tabletsq2resistq2disintegrationq2inq2theq2acidicq2environmentq2ofq2theq2stomachq2andq2disintegr
ateq2whenq2theyq2reachq2theq2smallq2intestine.q2Thereq2isq2usuallyq2someq2delayq2inq2onsetq2ofq2actionsq2
afterq2takingq2theseq2medications.q2Enteric-
coatedq2tabletsq2shouldq2notq2beq2crushedq2orq2chewed,q2whichq2wouldq2alterq2theq2timeq2andq2location
q2 ofq2absorption.q2Acidicq2foodsq2willq2notq2enhanceq2theq2absorptionq2ofq2theq2medication.q2Theq2patie
ntq2shouldq2notq2toq2eatq2high-fatq2foodq2beforeq2ingestingq2anq2enteric-
coatedq2tablet,q2becauseq2high-fatq2foodsq2decreaseq2theq2absorptionq2rate.
DIF:q2COGNITIVEq2LEVEL:q2Applyingq2(Application)q2REF:q2dmq2
3q2TOP:q2NURSINGq2PROCESS:q2Nursingq2Intervention
MSC:q2NCLEX:q2Physiologicalq2Integrity:q2Pharmacologicalq2andq2 Parenteralq2Therapies
4. Aq2patientq2whoq2isq2newlyq2diagnosedq2withq2typeq21q2diabetesq2mellitusq2asksq2whyq2insulinq2m
ustq2beq2givenq2byq2subcutaneousq2injectionq2insteadq2ofq2byq2mouth.q2Theq2nurseq2willq2explainq2thatq
2thisq2isq2because
a. absorptionq2isq2 diminishedq2 byq2theq2first-passq2effectsq2inq2theq2liver.
b. absorptionq2isq2fasterq2whenq2insulinq2isq2givenq2subcutaneously.
c. digestiveq2enzymesq2inq2theq2gastrointestinalq2tractq2preventq2absorption.
d. theq2oralq2formq2isq2lessq2predictableq2withq2moreq2adverseq2eff
ects.q2ANS:q2C
Insulin,q2growthq2hormones,q2andq2otherq2protein-
basedq2drugsq2areq2destroyedq2inq2theq2smallq2intestineq2byq2digestiveq2enzymesq2andq2mustq2beq2given
q2 parenterally.q2Becauseq2insulinq2isq2destroyedq2byq2digestiveq2enzymes,q2itq2wouldq2notq2makeq2itq2t
oq2theq2liverq2forq2metabolismq2withq2aq2first-
passq2effect.q2Subcutaneousq2tissueq2hasq2fewerq2bloodq2vessels,q2soq2absorptionq2isq2slowerq2inq2suchq
2tissue.q2Insulinq2isq2givenq2subcutaneouslyq2becauseq2itq2isq2desirableq2toq2haveq2itq2absorbq2slowly.
Pageq 2 2q 2 ofq 2 507
Plusbay.Plus
, DIF:q2COGNITIVEq2LEVEL:q2Understandingq2(Comprehension)q2REF:q2dmq2
3q2TOP:q2NURSINGq2PROCESS:q2Nursingq2Intervention:q2Patientq2Teaching
MSC:q2NCLEX:q2Physiologicalq2Integrity:q2Pharmacologicalq2andq2 Parenteralq2Therapies
Pageq 2 3q 2 ofq 2 507
Plusbay.Plus